Long-lasting treatment suppresses HIV in people with mental illness and other conditions that make it challenging to adhere to standard treatments.

Better living through chemistry: in Resident Evil Requiem, Grace Ashcroft can find and create special injections that give her permanent stat boosts, though ...

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

LIB Therapeutics has scored an FDA approval for its cholesterol-lowering, third-generation PCSK9 inhibitor, lerodalcibep-liga. The injected treatment, which will carry the commercial name Lerochol, is ...

What we're doing is that I'll be showing you how I usually clean intake valve deposits on gasoline direct injection engines on the DIY, efficiently, and with consistent good results, and then along ...

As the year winds down, injection molds and machines deserve a thorough tune-up to ensure smooth operations in the year ahead. Neglecting maintenance can lead to costly downtime and compromised ...

'Tis the season for holiday gift guides. You know, the ones that suggest 31 fish gifts for your fish-obsessed friends. They're everywhere this time of year, though nowhere quite as surprising as a ...

Blackford Capital has announced a strategic investment in Texas Injection Molding, providing the Houston-based manufacturer with capital for continued expansion and access to Blackford's expertise in ...

Most Medicare drug plans cover Repatha (evolocumab). This includes stand-alone Part D prescription drug plans and Medicare Advantage plans that include prescription drug coverage. Doctors prescribe ...

Amgen Chairman, President and CEO Bob Bradway joins 'Mad Money' host Jim Cramer to talk quarterly results, its recent drug trials, what is ahead for the company and more. Got a confidential news tip?

Nov 8 (Reuters) - Adding Amgen's (AMGN.O), opens new tab cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25% for at-risk patients who have never had a heart attack ...